Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|February 3, 2020
Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cellsStella Cascioferro, Giovanna Li Petri, Barbara Parrino, et al.
European Journal of Medicinal Chemistry|October 9, 2020
1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase ABarbara Parrino, Daniela Carbone, Stella Cascioferro, et al.
Cancers|November 4, 2020
"Open Sesame?": Biomarker Status of the Human Equilibrative Nucleoside Transporter-1 and Molecular Mechanisms Influencing its Expression and Activity in the Uptake and Cytotoxicity of Gemcitabine in Pancreatic CancerOrnella Randazzo, Filippo Papini, Giulia Mantini, et al.
Molecules (Basel, Switzerland)|January 18, 2020
3-(6-Phenylimidazo [2,1-b][1,3,4]thiadiazol-2-yl)-1H-Indole Derivatives as New Anticancer Agents in the Treatment of Pancreatic Ductal AdenocarcinomaStella Cascioferro, Giovanna Li Petri, Barbara Parrino, et al.
Bioorganic Chemistry|June 28, 2024
Triazole derivatives inhibit the VOR complex-mediated nuclear transport of extracellular particles: Potential application in cancer and HIV-1 infectionDaniela Carbone, Mark F Santos, Denis Corbeil, et al.
Anticancer Research|September 4, 2020
New Imidazo[2,1-b][1,3,4]Thiadiazole Derivatives Inhibit FAK Phosphorylation and Potentiate the Antiproliferative Effects of Gemcitabine Through Modulation of the Human Equilibrative Nucleoside Transporter-1 in Peritoneal MesotheliomaGiovanna Li Petri, Camilla Pecoraro, Ornella Randazzo, et al.
International Journal of Biological Sciences|June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic TargetRocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
European Journal of Medicinal Chemistry|March 14, 2022
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identificationDaniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
Cancer Drug Resistance (Alhambra, Calif.)|November 24, 2025
Novel FAK inhibitors suppress tumor growth and reverse EGFR-TKI resistance in non-small cell lung cancerGeng Xu, Camilla Pecoraro, Mahrou Vahabi, et al.
Antioxidants (Basel, Switzerland)|August 26, 2023
A Combination of Polymethoxyflavones from Citrus sinensis and Prenylflavonoids from Humulus lupulus Counteracts IL-1β-Induced Differentiated Caco-2 Cells Dysfunction via a Modulation of NF-κB/Nrf2 ActivationIgnazio Restivo, Manuela Giovanna Basilicata, Ilenia Concetta Giardina, et al.
Pageof 5